Akebia Therapeutics, Inc.
10-K
February 26, 2026
Key Highlights
- Akebia achieved strong financial performance in 2024 with total revenues of $250...
- The company expanded Vafseo's global commercialization rights and strategically ...
- Akebia ended 2024 with $125 million in cash and cash equivalents and anticipates...
Read Analysis
🤖 AI Generated